Wedmont Private Capital

Position in NVS — Novartis AG

CIK 1904274 WEST CHESTER, PA

Position in NVS

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$923,707

-$98,496 QoQ

Shares Held

5,894

-11.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#648

of 1,603 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Wedmont Private Capital holds $55,219,944 across 14 Drug Manufacturers - General names. NVS ranks #10 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	16,064	$19,267,645
2	ABBV	AbbVie Inc.	43,731	$11,004,468
3	JNJ	Johnson & Johnson	34,052	$8,648,186
4	GILD	Gilead Sciences, Inc.	32,598	$4,118,431
5	MRK	Merck & Co., Inc.	28,290	$3,635,265
6	AMGN	Amgen Inc	8,666	$3,138,131
7	BMY	Bristol Myers Squibb Co	19,243	$1,108,781
8	PFE	Pfizer Inc	41,785	$1,006,182

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$923,707	5,894	-11.9%	Shares	Sole	2026-07-13
2026-03-31	$1,022,203	6,692	-9.8%	Shares	Sole	2026-04-09
2025-12-31	$1,022,443	7,416	+14.7%	Shares	Sole	2026-01-08
2025-09-30	$829,328	6,467	-1.0%	Shares	Sole	2025-10-08
2025-06-30	$790,558	6,533	+0.5%	Shares	Sole	2025-07-10
2025-03-31	$724,731	6,501	+2.4%	Shares	Sole	2025-04-14
2024-12-31	$617,723	6,348	+2.6%	Shares	Sole	2025-01-13
2024-09-30	$711,973	6,190	+5.4%	Shares	Sole	2024-10-08
2024-06-30	$625,346	5,874	+17.1%	Shares	Sole	2024-07-15
2024-03-31	$485,294	5,017	+0.2%	Shares	Sole	2024-04-10
2023-12-31	$505,758	5,009	+34.3%	Shares	Sole	2024-01-09
2023-09-30	$380,039	3,731	+28.7%	Shares	Sole	2023-10-10
2023-06-30	$292,538	2,899	—	Shares	Sole	2023-07-17
No filing history on record for this holder in this stock.